Key result
Loss of alleles on chromosomes 11p (4 of 6 patients), 13q (3 of 6), and 17p (all heterozygous patients) occurred in adrenocortical carcinomas but not in benign adrenal lesions.
Observational (n=17)
Consistent genetic changes involving loss of alleles on chromosomes 11p, 13q, and 17p are implicated in the pathogenesis of adrenocortical carcinoma.
Answers are grounded in this paper and cite their sources.
Allelic losses may distinguish adrenocortical carcinomas from benign lesions; hypothesis-generating and should not yet change practice.
Recent studies have suggested that loss of heterozygosity at loci on the short arm of human chromosome 11 (11p) may be important in the pathogenesis of benign and malignant adrenal cortical tumors. To test this concept, adrenocortical carcinomas from nine patients and benign adrenal cortical lesions from eight patients were tested for loss of alleles at loci on human chromosomes 11, 13, and 17. All patients with adrenocortical carcinoma whose normal somatic tissues were heterozygous for a locus on chromosome 17p had lost alleles in the tumor. Four of six patients with adrenocortical carcinoma who were heterozygous for one or more alleles on chromosome 11p in normal tissues had lost 11p alleles in the tumor. Three of six patients with adrenocortical carcinoma showed loss of 13q alleles in the tumor. Loss of alleles on chromosomes 11p, 13q, and 17p was observed in primary tumors and metastases but not in adrenocortical adenomas or hyperplastic lesions of the adrenal cortex. One patient with adrenocortical carcinoma had a somatic mutation in the HRAS1 gene in the normal adrenal gland. The consistency of the genetic changes on chromosomes 11p, 13q, and 17p suggests that they are important in the pathogenesis of adrenocortical carcinoma.
No takes yet. Share an insight, caveat, or question.
Yano et al. (1989) conducted an observational in Adrenocortical carcinomas and benign adrenal cortical lesions (n=17). Adrenocortical carcinoma vs. Benign adrenal cortical lesions was evaluated on Loss of alleles at loci on human chromosomes 11, 13, and 17. Loss of alleles on chromosomes 11p (4 of 6 patients), 13q (3 of 6), and 17p (all heterozygous patients) occurred in adrenocortical carcinomas but not in benign adrenal lesions.
Synapse has enriched 10 related papers. Consider them for comparative context: